ClinicalTrialsFinder

Advanced Relapsed or Refractory Ovarian Cancer Clinical Trials in Chiba, Kashiwa

1 recruitingChiba, Kashiwa, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Advanced Relapsed or Refractory Germ Cell TumoursAdvanced Relapsed or Refractory Endometrial CancerAdvanced Relapsed or Refractory Ovarian Cancer
Boehringer Ingelheim187 enrolled13 locationsNCT07306559